Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Symple Surgical
Symple Surgical develops therapeutic microwave energy devices to modulate and monitor hyperactive sympathetic nerve signals.
Sector
Subsector
Keywords
Location
total rounds
total raised
DFine
DFine is a medical device company that provides innovative therapy for managing compression fractures of the spine.
Sector
Subsector
Location
total rounds
total raised
NanoVibronix
NanoVibronix is a medical device company that develops portable devices using its proprietary therapeutic ultrasound technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
CardiaLen
CardiaLen develops pain-free cardioversion therapies for atrial fibrillation.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds7
Number of Funding Rounds
Money Raised
Their latest funding was raised on 02.05.2017. Their latest investor NBGI Ventures. Their latest round Venture - Series Unknown
Questa Capital Management
Questa Capital Management invests in healthcare companies with disruptive business models.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
New Enterprise Associates
NEA is a global venture capital firm that helps entrepreneurs build innovative businesses in technology and healthcare.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Ajax Health
Ajax Health is a venture capital firm that accelerates medical innovation.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
New Enterprise Associates
NEA is a global venture capital firm that helps entrepreneurs build innovative businesses in technology and healthcare.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
NBGI Ventures
NBGI Ventures is a venture capital fund focused on investing in medical technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Keiretsu Forum
Keiretsu Forum connects accredited private equity investors, venture capitalists and corporate/institutional investors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
New Enterprise Associates
NEA is a global venture capital firm that helps entrepreneurs build innovative businesses in technology and healthcare.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Justin Klein
Justin joined NEA in 2006 and is a Partner on the healthcare team. He focuses on medical device, healthcare technology, and biopharmaceutical company investments. He serves as a director of Advanced Cardiac Therapeutics, Cartiva, FIRE1, Intact Vascular, PhaseBio Pharmaceuticals, Relievant Medsystems, Senseonics, VertiFlex, and VytronUS. Justin’s past board memberships and investments include CV Ingenuity (acquired by Covidien), Nevro (NYSE: NVRO), Topera (acquired by Abbott), TriVascular (NASDAQ: TRIV), and Ulthera (acquired by Merz). He is also a member of the advisory boards for the National Venture Capital Association’s Medical Industry Group and its Medical Innovation and Competitiveness Coalition (MedIC), as well as a member of AdvaMed's Business Development Committee. Prior to NEA, Justin worked for the Duke University Health System—reporting directly to the hospital CEO on health system strategy, finance and clinical service unit operations—as Duke built one of the nation's first and largest healthcare integrated delivery systems. Justin concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School. He has also served as a member of the Board of Trustees of Duke University, where he earned his AB in Economics and his BS in Biological Anthropology and Anatomy.
current job
People
Founders2
Duke Rohlen
Douglas S. Rohlen, also known as Duke, serves as Chief Executive Officer of Ajax Health LLC. Duke Rohlen serves as an Executive Chairman of EPIX Therapeutics, Inc., and has been its Chief Executive Officer. He is a Co-Founder of Ajax Vascular and serves as its Chief Executive Officer. He is a General Partner of D3DC, LLC. He has over two decades of experience in cardiovascular medical devices. He served as the Chief Executive Officer and President at Spirox, Inc. He was a Co-Founder of CV Ingenuity Corp., and served as its President and Chief Executive Officer. He was a Managing Partner of TauTona Group. He served as President of Fox Technologies. He served as Head of Investor Relations at Foxhollow Technologies Inc. He served as President of Strategic Operations at Foxhollow Technologies Inc. Duke Rohlen served as Vice President of Corporate Development and Investor Relations and as Director of Business Development since joining Foxhollow Technologies Inc., he served as President and Chief Executive Officer of Olive Hill Development, a land development company. He served as a Project Consultant at Massachusetts General Hospital. He served as Director of Business Development at LuMend Corporation, a privately-held company that develops chronic total occlusion products in the treatment of peripheral vascular disease which was acquired by Cordis Corporation. In 1999, he served as Entrepreneur in Residence at Alta Partners, a venture capital firm. He served as a Director of Entellus Medical, Inc., Duke Rohlen holds a B.A. in History from Stanford University and an MBA from Harvard Business School.
current job
organization founded
Duke Rohlen